Picture of Penumbra logo

PEN Penumbra Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Penumbra, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line47-19.32.62-291
Depreciation
Deferred Taxes
Non-Cash Items26.643.171.342.177.3
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-56.8-51.2-66.7-122-79.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities26.7-33.29.5-55.797.3
Capital Expenditures-22.1-24.8-21.2-19.3-15.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items9.4-79.4-0.55574.1-0.863
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-12.7-104-21.754.8-16.1
Financing Cash Flow Items-19.5-13-16.1-8.18-2.23
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-8.961350.83611.616.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4.93-3.11-10.310.597.6